Concept Change of Percutaneous Coronary Intervention for Patients With Stable Coronary Heart Disease
10.3969/j.issn.1000-3614.2025.01.012
- VernacularTitle:稳定性冠心病患者经皮冠状动脉介入治疗理念的变迁
- Author:
Minghui LI
1
;
Yongjian WU
1
Author Information
1. 中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院 冠心病中心,北京 100037
- Publication Type:Journal Article
- Keywords:
stable coronary heart disease;
percutaneous coronary intervention;
evidence-based medicine;
treatment concept
- From:
Chinese Circulation Journal
2025;40(1):95-99
- CountryChina
- Language:Chinese
-
Abstract:
Since the first report of percutaneous transluminal coronary angioplasty for patients with coronary heart disease in 1977,percutaneous coronary intervention(PCI)has been rapidly developed and comprehensively popularized,and is considered to be the most effective method for the treatment of coronary heart disease.Clinical trials have demonstrated that PCI could reduce the risk of major cardiovascular events in patients with acute coronary syndrome.However,the effectiveness of PCI in patients with stable coronary artery disease(SCAD)has been controversial.In addition,the rapid development of drugs,interventional devices and diagnostic techniques has continuously challenged the concept of PCI treatment for patients with SCAD.This article reviews the evidence-based medical evidence of PCI for treatment of SCAD,sorts out the changes in the concept of PCI for SCAD at different stages,and looks forward to the future prospects of PCI for SCAD.
